Table 3 Comparison between percent area of TGF-β 1 expression in the submucosa, controls versus CRSwNP patients
Submucosa | |||
|---|---|---|---|
CRSwNP | Control | ||
1 | 35.07% | 1 | 20.56% |
2 | 12.23% | 2 | 0.00% |
3 | 24.66% | 3 | 0.00% |
4 | 18.53% | 4 | 0.00% |
5 | 19.75% | 5 | 10.80% |
6 | 17.15% | 6 | 0.00% |
7 | 22.16% | 7 | 0.00% |
8 | 25.64% | 8 | 0.00% |
9 | 20.26% | 9 | 15.54% |
10 | 18.00% | 10 | 15.77% |
11 | 44.06% | 11 | 0.00% |
12 | 25.82% | ||
13 | 31,50% | ||
14 | 34.60% | ||
15 | 13.17% | ||
16 | 20.64% | ||
17 | 11.87% | ||